Bausch Health Companies I...

7.27
0.11 (1.54%)
At close: Mar 24, 2025, 3:59 PM
7.09
-2.45%
After-hours: Mar 24, 2025, 08:00 PM EDT
1.54%
Bid 6.78
Market Cap 2.67B
Revenue (ttm) 9.61B
Net Income (ttm) -45.71M
EPS (ttm) -0.13
PE Ratio (ttm) -55.92
Forward PE 1.72
Analyst Hold
Ask 7.4
Volume 1,294,734
Avg. Volume (20D) 2,619,936
Open 7.18
Previous Close 7.16
Day's Range 7.09 - 7.29
52-Week Range 3.96 - 11.46
Beta 0.60

About BHC

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on...

Sector Healthcare
IPO Date Mar 29, 1994
Employees 20,700
Stock Exchange NYSE
Ticker Symbol BHC
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for BHC stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 10.04% from the latest price.

Stock Forecasts

Next Earnings Release

Bausch Health Companies Inc. is scheduled to release its earnings on May 1, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+10.29%
Bausch Health shares are trading higher after the ... Unlock content with Pro Subscription
1 month ago
-10.9%
Bausch Health shares are trading lower after the company announced it will continue to own its 88% interest in Bausch + Lomb.